| 12/12/2024 13:15 |
Corporate Governance Report |
| 11/06/2024 12:00 |
Notice Regarding Extension of Trust Term and an Additional Financial Contribution to the ESOP Trust |
| 11/06/2024 12:00 |
Consolidated Financial Result Digest FY2025/3 2Q (Fiscal Year Ended March 31,2025) |
| 11/06/2024 12:00 |
Notice of Revised Full-year Earnings Forecasts for the Fiscal Year Ended March 31,2025 |
| 11/06/2024 12:00 |
Consolidated Financial Results for the Six Months of the Fiscal Year Ended March 31,2025 |
| 09/17/2024 15:30 |
Notice Regarding Personnel Changes |
| 09/17/2024 15:30 |
Notice Regarding an Additional Financial Contribution to the ESOP Trust |
| 08/01/2024 12:00 |
Notice of Revised the First-half and Full-year Earnings Forecasts for the Fiscal Year Ended March 31, 2025 |
| 08/01/2024 12:00 |
Consolidated Financial Result Digest FY2025/3 Q1 (Fiscal Year Ended March 31, 2025) |
| 08/01/2024 12:00 |
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025 |
| 07/26/2024 15:30 |
[Delayed]Corporate Governance Report |
| 07/09/2024 15:30 |
Notice Regarding Completion of Payment for New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System |
| 06/27/2024 15:30 |
[Delayed]Notice Regarding Issuance of New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System |
| 06/20/2024 12:00 |
Notice Regarding Personnel Changes |
| 06/17/2024 08:30 |
Matters Concerning Controlling Shareholders, Etc. |
| 06/17/2024 08:30 |
Notice Regarding Personnel Changes |
| 06/17/2024 08:30 |
Notice Regarding Chairman of the Board of Directors |
| 06/17/2024 08:30 |
Notice Regarding Responsibilities of Board Directors |
| 06/13/2024 12:00 |
[Delayed]Notice Regarding Partial Amendment of the Articles of Incorporation |
| 06/13/2024 12:00 |
[Delayed]Notice Regarding Company's Propositions For 78th Ordinary General Shareholders' Meeting |
| 05/13/2024 15:30 |
Notice Regarding Introduction of Post Issuance-Type Restricted Stock Granting Plan for Executive Officers, Etc. |
| 05/13/2024 15:30 |
Notice Regarding the Change of the Candidates for Board Directors |
| 05/01/2024 12:00 |
Notice Regarding Personnel Changes |
| 05/01/2024 12:00 |
Consolidated Financial Result Digest FY2024/3 Q4 (Fiscal Year Ended March 31, 2024) |
| 05/01/2024 12:00 |
Notice Regarding Recognition of Extraordinary Losses |
| 05/01/2024 12:00 |
Notice regarding dividends from surplus |
| 05/01/2024 12:00 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 |
| 04/10/2024 15:35 |
Notice Regarding Change of Major Shareholder |
| 04/01/2024 15:30 |
Notice regarding acquisition and acquisition completion of Treasury Stock |
| 03/15/2024 15:30 |
Notice Regarding Personnel Changes |
| 03/15/2024 15:30 |
Notice of the Candidates for Board Directors |
| 03/08/2024 15:30 |
Notice regarding acquisition of Treasury Stock |
| 02/15/2024 15:00 |
Notice Regarding Receiving Manufacturing and Marketing Approval for Additional Formulation, Madopar L50 Combination Tablets |
| 02/09/2024 15:30 |
Notice regarding acquisition of Treasury Stock |
| 02/02/2024 12:00 |
Consolidated Financial Result Digest FY2024/3 Q3 (Fiscal Year Ended March 31, 2024) |
| 02/02/2024 12:00 |
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ended March 31, 2024 |
